EU regulator to issue advice on Johnson & Johnson COVID-19 vaccine

Experts at the European Medicines Agency are preparing to present Tuesday the conclusions of their investigation into possible links between the J&J COVID-19 vaccine and very rare cases of unusual clotting disorders detected in the U.S.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button